Search
for
Sort by
Research 361–390 of 1000+
- Systemic Lupus Erythematosus: What Every Clinician Needs to Know
- Polynucleotides Versus Platelet-Rich Plasma for Androgenetic Alopecia: A Case Series
- A scoping review of alopecia areata and its relationship to COVID-19 vaccinations
- Neuropathic Pruritus: An Underrecognized and Often Misdiagnosed and Difficult to Treat Medical Condition
- TONGUE, RED
- Androgenetic alopecia – Update 2022
- Folliculitis decalvans: a case report of satisfactory recovery after implementing isotretinoin therapy
- Erosive pustular dermatosis (chronic atrophic dermatosis of the scalp and extremities)
- Nonscarring alopecia after temporal lifting technique with dermal fillers
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Pharmacotherapy for Keloids and Hypertrophic Scars
- The Non-Cosmetic Dermatological Use of Botulinum Neurotoxin
- Alopecia Areata: An Updated Review for 2023
- Alopecia Areata: Current Treatments and New Directions
- Teledermatology in the COVID-19 pandemic: A systematic review
- Poster Presentations
- Bendamustine in Indolent Non-Hodgkin's Lymphoma: A Practice Guide for Patient Management
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Ruxolitinib found to cause eyelash growth: a case report
- Autophagy: Guardian of Skin Barrier
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Safety of Common Medications for Treating Dermatology Disorders in Pregnant Women
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- In Vivo Reflectance Confocal Microscopy in General Dermatology: How to Choose the Right Indication
- Impacts of COVID-19 Pandemic on Dermatology Outpatient Department at a Tertiary Hospital in Eastern China: A Pre-Post Study
- Erosive Pustular Dermatosis: Delving into Etiopathogenesis and Management
- Dermatoses in Postmenopausal Women in a Tertiary Health Care Center of Bihar: A Prospective Cross-Sectional Study
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway